INCYTE CORP 4

EVP & Chief Scientific Officer Patrick A. Mayes had 1,949 Incyte Corp. common shares withheld for tax on RSU settlements, leaving him with 57,712 directly held shares.

On July 14 and 15, 2026, Incyte Corporation EVP & Chief Scientific Officer Patrick A. Mayes had a total of 1,949 shares of common stock withheld by the company to cover tax obligations arising from the settlement of previously granted restricted stock units, at effective prices of approximately $114.88 and $115.09 per share, respectively. These Form 4-reported transactions are non-open-market, tax-withholding entries (coded as 'F') rather than discretionary buys or sells, reducing his directly held shares from 59,661 to 57,712 while leaving substantial additional upside exposure through 53,621 unvested RSUs that remain outstanding. Based on the indicated share prices, the withheld shares represent an aggregate value of roughly $223,000, and his post-transaction direct holdings are worth about $6.6 million at the same price level, not including the value of unvested RSUs.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0002079962-26-000009

Alert Tier

5